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Abstract 
Synthetic biology is an emerging field at the interface between biology and engineering, 
which has generated many expectations for beneficial biomedical and biotechnological 
applications. At the same time, however, it has also raised concerns about risks and benefits 5 
or about the aim of producing new forms of living organisms. Researchers from different 
disciplines as well as policy makers and the general public have expressed the need for a form 
of technology assessment that does not only deal with technical aspects, but also includes 
societal and ethical issues. A recent and very influential model of technology assessment that 
tries to implement these aims is known as RRI ("Responsible Research and Innovation"). In 10 
this paper we introduce this model and its historical precursor strategies. Based on the societal 
and ethical issues which are presented in the current literature, we discuss challenges and 
opportunities of applying the RRI model for the assessment of synthetic biology. 
 
Introduction 15 
Synthetic biology as an emerging field at the interface between biology and engineering has 
raised many expectations for beneficial and revolutionizing applications, for instance in 
medicine, for the production of biofuels or for bioremediation. However, there are also 
concerns that synthetic biology might have negative consequences, such as impacts related to 
intellectual property rights, potential abuse or unknown side-effects. Moreover, it has been 20 
suggested that this new field could raise concerns related to the aim of producing new life 
forms, which may be perceived as artificial organisms and thus as unnatural. It is important to 
take potentially negative side-effects of biotechnologies and related concerns of the public 
seriously. Therefore, different strategies to study risks as well as economic, societal and 
ethical implications of emerging technologies have been developed. The most recent model 25 
runs under the acronym of "RRI", which stands for "Responsible Research and Innovation". 
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This review will introduce RRI for synthetic biology. In the first part we provide an overview 
of the societal and ethical implications of synthetic biology which have been examined in the 
academic literature. We then introduce the model of RRI and its historical precursor 
strategies. The final part will discuss the challenges and future directions of the RRI model for 
synthetic biology by reflecting the ethical and societal issues in context of the RRI 5 
framework. 
 
1. Different types of concerns on societal and ethical implications of synthetic biology 
Synthetic biology is an interdisciplinary field at the interface between biology and 
engineering, which involves different disciplines such as molecular biology, system biology, 10 
biophysics and biotechnology as well as engineering sciences and information technology. It 
is sometimes described as an extension of earlier forms of genetic engineering. However, the 
aim is not only to produce new kinds of modified organisms, but also to understand complex 
biological systems and networks by constructing biological modules and systems that may or 
may not exist in nature [1,2]. Possible applications of biological systems resulting from 15 
synthetic biology could range from energy production through the invention of biomaterials 
and tools for environmental remediation to various medical applications [3,4]. The latter 
include so-called theranostic systems, which can sense disease markers and respond by the 
direct production of therapeutic molecules [5]. 
The potential of synthetic biology generates hopes and promises. However, at the same 20 
time there are also concerns and fears that this technology drifts too far away from nature. The 
academic literature has discussed different issues and concerns within the current debate 
[6,7,8,9,10,11]. Many concerns are known from the debate over "Genetically Modified 
Organisms" (GMO) and have been anticipated to be similar for synthetic biology [12]. 
However, synthetic biology allows for new dimensions of creativity in biotechnology and 25 
novel products that are further away from their natural origins than previous forms of gene 
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technology. Moreover, entirely new types of applications are discussed for this technology, 
which go along with novel opportunities as well as risks and economic challenges. In the 
following section, we distinguish between three types of societal and ethical concerns 
commonly addressed in the academic literature. 
 5 
1.1. Technical and risk-related concerns 
Concerns under this header deal with different risks for human health and the environment. 
Two different types of concerns are distinguished related to respective risk prevention 
strategies. Biosafety is the strategy to improve laboratory safety, avoid unintended 
consequences and deal with the uncontrolled release of synthetic biology products. 10 
Biosecurity strategies deal with bioterrorism and the military usage of synthetic organisms. 
• Biosafety: Pathogens, toxins or otherwise harmful or potentially harmful biological 
material produced through synthetic biology could be released accidently from a 
laboratory [1,7,13]. Moreover, unintended side-effects of synthetic biology products 
created for a certain task (e.g. modified microorganisms used for bioremediation) could 15 
occur in the environment and negatively influence human health and other organisms 
[1,13]. Other risks include the contamination of the natural gene pool through accidental 
release of synthetic biology products. 
• Biosecurity: A risk that is widely recognized by the scientific community is that 
synthetic biology could be misused for the design of pathogens for the purposes of 20 
bioterrorism or biological weapons [6,14,15]. Although this dual-use dilemma has been 
known in life sciences before, the new technical potential of synthetic biology including 
the possibility of synthesizing the genome of pathogenic viruses or of combining 
different traits to render microorganism more dangerous have exacerbated the risk of 
misuse [16]. 25 
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1.2. Concerns about availability and distribution 
Besides these risk-related issues there are concerns that deal with the availability and 
distribution of synthetic biology and its applications or products. These concerns touch social 
and economic implications as well as questions of justice and fairness. 
• Patenting and creation of monopolies: The great expectations of novel products in 5 
synthetic biology have triggered a debate over the role of patenting and intellectual 
property regimes [17]. It has been discussed, for instance, whether patenting of 
synthetic biology products and processes may lead to the creation of commercial 
monopolies [17,18]. Moreover, there is a risk that such patents might inhibit innovation 
in synthetic biology rather than promoting it [9,19,20]. 10 
• Distribution of benefits and risks: Both, patenting and the potential of monopolies on 
certain products or applications in the field of synthetic biology, raise concerns that 
access to the associated knowledge and applications will be unfairly restricted and 
controlled [11,21]. These concerns – subsumed under the header of justice and fairness 
– are related to the distribution of benefits and burdens within a society and across the 15 
globe. Besides the distribution itself, the question of who should decide how benefits 
and risks should be distributed has been raised [21,22]. 
 
1.3. Concerns about "unnatural life" 
The third type of concerns relates to the application of engineering principles and procedures 20 
to living organisms in order to design new forms of life. In context of the famous synthetic 
biology competition iGEM ("The international Genetically Engineered Machine 
Competition"), scientists even speak of genetically engineered 'machines'. 
• Creating artificial life: The engineering-driven approach of understanding living 
organisms raised moral concerns about the possibility that artificial life might be created 25 
and that this could amount to interference with nature [10,23,24]. Some ethicists argue 
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that living organisms have a moral status, meaning that they should be treated 
differently from mere things: for such positions, synthetic biology raises the question of 
whether this status may be affected by the artificial nature of these organisms 
[25,26,27]. Speaking of a moral status in living organisms evokes the fear that 
researchers in synthetic biology are 'playing God' or – in a more secular sense –are 5 
'tampering with nature'. The question 'What is life?' can be interpreted differently – 
referring to a variety of philosophical, religious or scientific concepts [24,28,29]. 
Certain views on life go along with the idea that life should be 'natural'. This raises 
concerns about the unnatural aspect of synthetic biology products [30,31]. Another 
common moral concern claims that synthetic biology has a reductionist approach and 10 
erodes the distinction between organisms and machines [20]. 
 
2. Responsible research and innovation in the field of synthetic biology – challenges and 
prospects 
Not only academics in the literature but also the lay public have expressed issues and 15 
concerns as those mentioned above [31,32,33]. Since it is the scientific work that has caused 
these concerns, it has been suggested that scientists should interact with the public and discuss 
its societal and ethical concerns. Various approaches towards the assessment and governance 
of emerging technologies – such as synthetic biology – have been developed. Recent 
approaches put a particular emphasis on considering societal and ethical concerns of the 20 
public. It has been suggested that scientists could assume their responsibility towards society 
in participatory approaches. In such approaches scientists interact with the public in the form 
of stakeholders or selected representatives to assess the technology in question. Particularly in 
Europe, the currently most influential model of assessing, evaluating and accompanying 
emerging technologies together with the public is known as "Responsible Research and 25 
Innovation" (RRI). In the following section, we introduce the model of RRI and compare it to 
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its historical precursors. Subsequently, we will give a short overview of the current debate 
over the application of the RRI model in synthetic biology. 
 
2.1. RRI and its historical precursors 
The idea that the development of technologies goes along with responsibilities of scientists 5 
and engineers towards society is not new. Historical precursors or related concepts of RRI are 
different versions of "technology assessment" (TA) and so-called ELSI/ELSA programs1, 
where the acronym stands for "ethical, legal and social implications" or "aspects". Although 
these different models all deal with the impact of science and research on society and the 
environment, the focus of what constitutes responsible research has slightly shifted with the 10 
transition from one model to the other. 
Technology assessment (TA) is one of the main roots of RRI. It was the leading approach 
of evaluating and regulating new technologies from the 1970s to the 1990s [34]. The aim of 
the traditional TA approach was to evaluate new technologies in order to give early warnings 
and avoid or compensate anticipated negative impacts. Originally, this model was more 15 
focused on a technical evaluation than on the discussion of ethical issues. In the mid-1980s 
Arie Rip and colleagues have refined this model by considering feedbacks from users and the 
society for the design and construction of new technologies [35]. This revised version of TA 
was called "constructive technology assessment" (cTA) [35]. Another TA-model called 
"participatory technology assessment" (pTA) does not set as much emphasis on the design of 20 
the assessed technology as cTA. Instead, it evaluates the impact that a technology has for 
society by involving public actors [36]. Such representatives from the public include citizens, 
consumers and interest groups; they are part of the process of assessing and debating socially 
sensitive scientific and technological issues [37]. 
                                                 
1 While the acronym "ELSA" is commonly used in Europe, "ELSI" is more prevalent in the USA. 
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The ELSA/ELSI model became well-known in the 2000s and had their 'golden years' 
between 2002 and 2012 [38]. The first example of such a program dates back to 1988 when 
James Watson as director of the "Human Genome Project" (HGP) declared at a press 
conference that the ethical and social implications of genomics warrant a special effort and 
should be directly funded as part of the HGP by the U.S. National Institutes of Health (NIH) 5 
[39]. The first program funded by the NIH was then launched in 1990. Since 2000 
ELSA/ELSI became rather popular and programs were initiated in Canada, South Korea and 
Europe. Typically, the ELSA/ELSI model is embedded in large-scale scientific programs and 
addresses the interaction between internal technological and external social processes that 
could shape technological evolution. In contrast to the classical TA-approaches, these 10 
programs explicitly address ethical and legal aspects. As a consequence, the ELSA/ELSI 
model focuses on interdisciplinary collaborations as well as interactions with different 
stakeholders from society. 
The RRI model is a recent science governance approach which emerged around the 2010s 
and has been included in the "European Framework Programmes". The RRI model takes up 15 
many elements of ELSA/ELSI; therefore, it has been argued that the differences between 
ELSA/ELSI and RRI tend to be exaggerated [38]. RRI considers societal needs and concerns 
through an interactive process in which societal stakeholders and innovators respond to each 
other [40,41,42]. The RRI model suggests that responsible developments in science, 
technology and industry should be combined in the way that responsible innovations are 20 
anticipatory, reflective, deliberative and responsive [43]. The inclusion of ethical acceptability 
and societal desirability in the process of innovation is considered to be helpful to better 
embed scientific and technological advances in society [41]. Thus it has been suggested that 
ethical reflection and anticipation should be included in the research agenda of the assessment 
of emerging technologies. The involvement of these topics should help to analyze and 25 
interpret technological applications and their presumable future impact on society and the 
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environment. In comparison to ELIS/ELSA, the RRI approach is more focused on socio-
economic benefits and collaboration with private and industrial partners [38]. Moreover, RRI 
should accompany the research process rather than evaluating its consequences [44,45]. For 
this purpose, the research community and the education community should be brought 
together with representatives from industry and business as well as from the general public 5 
and policy makers [46]. According to the European Union [46], RRI is not only characterized 
by public engagement and the inclusion of ethical issues, but also by aspects such as science 
education and open access to knowledge. 
In the contemporary literature on the RRI model, different strategies to make RRI 
operative and effective have been discussed [40,41,42,47]. For instance, establishing a 10 
responsible research includes addressing societal needs and challenges in defining the purpose 
of science [42]. According to the RRI model, bearing responsibility would mean that 
scientists interact with the public in a democratic deliberative approach. Democratic 
deliberation can be understood as an active participation of citizens and a form of 
collaborative decision-making that embraces a respectful debate of opposing views [9]. The 15 
inclusion of the public can happen in the form of consensus conferences, citizens' juries, 
deliberative mapping, deliberative polling or focus groups [40]. 
 
2.2. Establishing RRI in the field of synthetic biology 
The reflection on the societal and ethical implications of synthetic biology began at an early 20 
stage – almost in parallel to the emergence of this novel field. Based on the experience with 
the debate over green gene technology, the scientific community wanted to avoid making the 
same mistakes of introducing a new technology before its ethical and societal implications 
were discussed. Shortly after the first viral and bacterial genomes were produced synthetically 
at the beginning of the new millennium, first publications – authored, among others, by 25 
scientists – discussed synthetic biology from the perspective of "technology assessment" 
Societal impact of synthetic biology: responsible research and innovation 
10 
[6,14,16,48,49]. Issues that were discussed in these publications included the previously 
introduced concerns on bioterrorism, biosecurity, laboratory safety, environmental protection, 
intellectual property rights and general ethical concerns. 
Since the emergence of synthetic biology, different initiatives and programs were launched 
worldwide to anticipate and discuss its societal and ethical implications. Examples include the 5 
U.S. programs "Synthetic Biology Engineering Research Center" (SynBERC), running since 
2006, and "Synthetic Biology Project" (www.synbioproject.org), starting in 2008, the 
European project "Making Perfect Life", which was launched in 2009 by the Science and 
Technology Options Assessment (STOA) panel of the European Parliament, or the national 
projects "Engineering Life" and "SynbioTA", both launched in 2010 by the Federal Ministry 10 
of Education and Research in Germany. Other national and transnational activities were, for 
instance, the programs "SYNBIOSAFE" (2007-2008), "SYBHEL" (2008-2012), "Synthetics" 
(2009-2011), "GEST" (2011-2014), "SynGovernance" (2012-2014) and "Synenergene" 
(2013-2016). All of these initiatives and programs included or focused on the ethical and 
societal implications of synthetic biology and referred to the ELSI/ELSA or the RRI model. 15 
Despite differences in their scopes and aims, there is a broad consensus among scientist 
within these programs that public engagement is essential for the development of regulatory 
regimes [50,51,52]. 
 
3. Challenges and future directions of RRI for synthetic biology 20 
So far the debate over synthetic biology and its societal and ethical implications have 
produced an impressive number of reports and academic publications. However, these 
documents are usually based on anticipated implications and anticipated risks and benefits of 
synthetic biology as there have not been any applications on the market yet [53]. Therefore, 
societal and ethical implications have usually been considered in comparison with similar 25 
applications from other biotechnologies (e.g. green gene technology) or by analyzing the 
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worldviews conveyed by the aims of synthetic biology that speak of engineered living 
organisms and synthetic cells [29]. This speculating nature is one of the main challenges for 
RRI programs on synthetic biology. 
As introduced above, RRI is usually implemented in the form of a participatory approach, 
meaning that scientists interact with the public by, for instance, establishing a dialogue to 5 
scrutinize ways in which emerging science is imagined, to explore possible future ways 
including societal and ethical issues or to define the direction of innovations [54]. Moreover, 
the research agenda of the RRI model includes the point of view of ethics and social sciences. 
In the following paragraphs we will address the challenges of implementing such an RRI 
model for synthetic biology. 10 
 
3.1. Challenges for applying RRI to synthetic biology 
One of the main challenges for applying the RRI model to synthetic biology is dealing with 
responsibility under the conditions of the high degree of uncertainty of the future directions of 
this novel field: compared to established technologies such as green gene technology there is 15 
almost no valid prospective knowledge available [53]. If the aim of anticipating and reflecting 
the impact of synthetic biology and the idea of a participatory approach of RRI are taken 
seriously, responsibility will not be demanded from scientists alone. It is a question of the 
distribution of responsibility [47]: stakeholder groups, the lay public as well as policy makers 
have to bear responsibility, too. Thus, as Cecilie Glerup and Maja Horst put it, responsibility 20 
is something that different actors learn together in a deliberative process [55]. In that sense, 
the RRI model – applied to synthetic biology – should be a task carried out by the whole 
society and not only by the scientific community. 
Another important challenge for applying RRI to synthetic biology is the great variety of 
possible products, applications and potential uses. Amy Wolfe, for instance, suggests 25 
establishing goals that do not just cover the type of production, but also determine how 
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research findings are used [56]. According to Wolfe, this kind of specificity in assessing and 
defining goals could support the research on societal aspects of synthetic biology as well as 
the process of public engagement [56]. Consequently, it may not be sufficient to define 
scientific and technical goals; in addition, a research agenda on societal and ethical 
perspectives has to be established. This would mean that – in parallel to the development of 5 
scientific and technical goals – there is a need for a strategy on how to integrate societal and 
ethical perspectives into the research agenda [57]. However, that seems to be a huge challenge 
due to the different kind of societal and ethical concerns raised by synthetic biology. 
Moreover, the integration of societal perspectives should influence innovation without 
preventing scientific curiosity and engineering creativity. 10 
The idea of giving a strong weight to the inclusion of the public in the RRI process goes 
along with several other challenges. One of them directly relates to the issues and concerns 
introduced in the first section: the public should certainly be involved because certain 
concerns only come to the light in direct consultation of laypersons. However, the 
identification of other issues requires the insight of experts and is not evident to the public. 15 
Moreover, experts are necessary for the analysis and interpretation of concerns, including 
those that have originally been raised by the public. This analysis should generate arguments 
that help to evaluate how these issues could influence the further development of synthetic 
biology. For such an analysis, different types of expertise and collaborations between 
scientists, engineers and researchers in social sciences and humanities are crucial [58]. In the 20 
following, we list some examples for points that should be considered in such an 
interdisciplinary collaboration: 
• Technical and risk-related concerns should be investigated with well-established 
technology-assessment tools that examine how synthetic biology products react, for 
instance, to different environmental conditions. 25 
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• Concerns about the availability and distribution of synthetic biology products should be 
analyzed and interpreted by experts from ethics and law as well as from social science 
and economics. 
• Experts from ethics and law, supported by those from social science and other 
disciplines, should scrutinized ethical concerns about creating artificial life. 5 
In consequence, it seems to be important that besides the inclusion of the public, the RRI 
framework should leave enough space for experts to examine the different societal and ethical 
issues, develop strategies on how to deal with them and how to communicate them. It is 
crucial that experts from science and other disciplines should communicate their analysis and 
interpretation in an open and transparent way to the laypersons in a public education as well 10 
as engagement process [29]. 
 
3.2. Future directions of the assessment of synthetic biology 
The discussion of societal and ethical implications of synthetic biology started at a very early 
stage. Therefore, a debate was established long before any concrete products had been 15 
developed. The discussion of societal and ethical issues is based, for instance, on an 
anticipation of new possibilities associated with synthetic biology as well as an analysis of the 
worldviews and aims conveyed by that technology, including the human relation to nature. 
Perhaps the early debate over the impacts of synthetic biology as well as the novel assessment 
approach of RRI might help to avoid conflicts as they are known from, for instance, green 20 
gene technology. However, it is still possible that the availability and commercialization of 
specific synthetic biology products might create novel conflicts. Helge Torgersen and Markus 
Schmidt argue that conflicts might be unavoidable and could be the best stimulus for an open 
and transparent debate [59]. This could mean that the aim of the RRI model to promote 
interactions between scientists, experts from other fields and the public might be a suitable 25 
framework to deal with certain conflicts in a constructive way. 
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The RRI model emphasizes that the focus on assessing an emerging technology like 
synthetic biology should not be focused on concerns about risks and negative consequences of 
a technology alone. Instead, technology assessment should also be included in the process of 
innovation and invention. One of the huge challenges certainly is to include the public in this 
process and to collectively analyze societal and ethical concerns amongst natural and social 5 
scientists. The implementation of the RRI model for synthetic biology has to manage the 
balancing act between shaping research and innovation through public participation and 
leaving enough space for scientific curiosity and engineering creativity. 
 
Summary  10 
• Synthetic biology as an emerging field at the interface between biology and 
engineering has raised concerns about risks, distribution and about the aim of 
producing new forms of living organisms.   
• RRI (Responsible Research and Innovation) is the most recent model to deal with risk 
and societal or ethical concerns. Well-known RRI precursors are: technology 15 
assessment (TA) and ELIS/ELSA (ethical, legal and social implications/aspects).   
• In comparison to the precursors, RRI sets a particularly strong focus on addressing 
ethical and societal issues already in the phase of innovation which should allow to 
include societal needs and priorities in shaping technological applications. For this 
purpose RRI emphasizes the importance of involving lay people in participatory 20 
processes.   
• Challenges for applying the RRI model to synthetic biology include 1) the uncertainty 
with respect to the possibilities in this techno-science, 2) finding apt models of 
involving the public, and 3) influencing the innovation process without hindering 
scientific curiosity and engineering creativity.   25 
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